DexCom (DXCM) Revenue — Quarter Ended Mar 31, 2024
Revenue declined from the immediately preceding quarter but increased compared to the same quarter one year earlier. The quarter-over-quarter drop contrasts with the sustained year-over-year growth.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue declined from the immediately preceding quarter but increased compared to the same quarter one year earlier. The quarter-over-quarter drop contrasts with the sustained year-over-year growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$921M
Revenue reported for this quarter.
Quarter-over-quarter
-11.0%
Change from the immediately preceding quarter.
Year-over-year
+24.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $871.3M | +25.2% |
| Sep 30, 2023 | $975M | +26.7% |
| Dec 31, 2023 | $1B | +26.9% |
| Mar 31, 2024 | $921M | +24.2% |
Revenue performance
The reported revenue for the quarter was lower than the prior quarter, while still showing a year-over-year improvement.
Quarterly comparison
Compared to the preceding quarter, revenue decreased. Compared to the same quarter one year earlier, revenue increased.
What to watch
Monitor the pattern of sequential revenue changes given the decline from the prior quarter.